Skip to main content
Top

International Journal of Clinical Oncology

Issue 3/2014

Content (22 Articles)

Special Article

Questionnaire-based survey on chemotherapy-induced anemia

Asashi Tanaka, Ichiro Yoshino, Shigeyoshi Makino, Noriyuki Katsumata, Koki Takahashi, Hiroyuki Kuwano, Yoshihiko Maehara, Masahiko Nishiyama

Introduction to Review Articles

Oral cancer: current status of molecular biology and treatment strategy

Tadaaki Kirita

Review Article

Update of molecular pathobiology in oral cancer: a review

Tomonori Sasahira, Tadaaki Kirita, Hiroki Kuniyasu

Original Article

Boron neutron capture therapy for advanced salivary gland carcinoma in head and neck

Teruhito Aihara, Norimasa Morita, Nobuhiko Kamitani, Hiroaki Kumada, Koji Ono, Junichi Hiratsuka, Tamotu Harada

Original Article

Predictive factors that influence the course of medullary thyroid carcinoma

Kalliopi Pazaitou-Panayiotou, Alexandra Chrisoulidou, Stylianos Mandanas, Konstantinos Tziomalos, Eleni Doumala, Frideriki Patakiouta

Original Article

Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients

Wakako Tsuji, Hiroshi Ishiguro, Sunao Tanaka, Megumi Takeuchi, Takayuki Ueno, Masakazu Toi

Original Article

Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes?

Harrison X. Bai, Sabin B. Motwani, Susan A. Higgins, Bruce G. Haffty, Lynn D. Wilson, Donald R. Lannin, Suzanne B. Evans, Meena S. Moran

Original Article

Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers

Ayako Yanai, Yoshimasa Miyagawa, Keiko Murase, Michiko Imamura, Tomoko Yagi, Shigetoshi Ichii, Yuichi Takatsuka, Takashi Ito, Seiichi Hirota, Mitsunori Sasa, Toyomasa Katagiri, Yasuo Miyoshi

Original Article

Intraoperative diagnosis of lymph node metastasis by transcription–reverse transcription concerted reaction assay in gastric cancer

Ryouichi Hirayama, Akiyoshi Seshimo, Kunitomo Miyake, Masako Nishizawa, Shingo Kameoka

Original Article

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

G. R. Varadhachary, S. Karanth, W. Qiao, H. R. Carlson, M. N. Raber, J. D. Hainsworth, F. A. Greco

Original Article

A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer

Kenya Yamanaka, Etsuro Hatano, Masashi Kanai, Shiro Tanaka, Keiichi Yamamoto, Masato Narita, Hiromitsu Nagata, Takamichi Ishii, Takahumi Machimoto, Kojiro Taura, Shinji Uemoto

Original Article

Prognosis analysis of sarcomatous intrahepatic cholangiocarcinoma from a review of the literature

Go Watanabe, Hiroshi Uchinami, Masato Yoshioka, Hiroshi Nanjo, Yuzo Yamamoto

Original Article

Development of a novel interferon-α2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro

Naotaka Fukui, Yukio Kageyama, Yotsuo Higashi, Kazunori Kihara, Shinae Kizaka-Kondoh, Masahiro Hiraoka, Toshiaki Shinojima, Kenjiro Suzuki, Mototsugu Oya

Original Article

Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice

Tomomi Kamba, Toshinari Yamasaki, Satoshi Teramukai, Noboru Shibasaki, Ryuichiro Arakaki, Hiromasa Sakamoto, Yoshiyuki Matsui, Kazutoshi Okubo, Koji Yoshimura, Osamu Ogawa

Original Article

Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma

Taku Naiki, Noriyasu Kawai, Yoshihiro Hashimoto, Takehiko Okamura, Ryosuke Ando, Takahiro Yasui, Atsushi Okada, Toshiki Etani, Keiichi Tozawa, Kenjiro Kohri

Original Article

Do hormone treatments for prostate cancer cause anxiety and depression?

Christopher F. Sharpley, David R. H. Christie, Vicki Bitsika

Original Article

Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer

Katsuyoshi Hashine, Hiroyuki Iio, Yoshiteru Ueno, Shohei Tsukimori, Iku Ninomiya

Original Article

High incidence of regional and in-transit lymph node metastasis in patients with alveolar rhabdomyosarcoma

Yoshihiro Nishida, Satoshi Tsukushi, Hiroshi Urakawa, Hideshi Sugiura, Hiroatsu Nakashima, Yoshihisa Yamada, Naoki Ishiguro

Original Article

NRAS mutations in primary and metastatic melanomas of Japanese patients

Hisashi Uhara, Atsuko Ashida, Hiroshi Koga, Eisaku Ogawa, Aya Uchiyama, Ryuhei Uchiyama, Koichi Hayashi, Yukiko Kiniwa, Ryuhei Okuyama

Original Article

Possible peripheral mechanism for taste disorder in rats administered S-1

Kumiko Aoki, Koji Obata, Miyako Kurihara, Hiroki Kuniyasu, Tadaaki Kirita, Miyako Takaki

Original Article

Usefulness of CT-lymphography in sentinel lymph node navigation

Masato Yasuta, Suguru Sato, Tomokazu Ishida, Takahiro Kiyohara

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine